Lisa Diehl

Director, Therapy Development

Lisa joined Metavention in January 2020 as Director of Therapy Development, with responsibilities for study site management in the U.S. With more than 25 years of sales, training and field clinical study leadership experience, Lisa has extensive background in innovative product launches at Covidien, Johnson and Johnson, and Cardiovascular Systems, Inc. Most recently, Lisa was Director of Therapy Development at ROX Medical. Lisa received her Bachelor of Arts degree from the University of Central Florida.